Under Trump, FDA seeks to abandon expert reviews of new drugs

Bearish -50.0
Advisory committee meetings help FDA scientists make decisions and increase public understanding of drug regulation, and abandoning them doesn't make sense, former officials said.
Read Source Login to use Pulse AI

Pulse AI Analysis

Pulse analysis not available yet. Click "Get Pulse" above.

This analysis was generated using Pulse AI, Glideslope's proprietary AI engine designed to interpret market sentiment and economic signals. Results are for informational purposes only and do not constitute financial advice.